RosVivo Therapeutics, Inc. signed a Material Transfer Agreemen...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, Feb. 22, 2022 /PRNewswire-AsiaNet/ -- - RSVI-301, a new drug candidate adopting miRNA technology, enters the technology export process.RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the...
Authors: LATEST ASIANET NEWS RELEASES